By Jenne Mannion Technology and smaller companies-themed funds were among the weaker performers over...
By Jenne Mannion Technology and smaller companies-themed funds were among the weaker performers over the second quarter of 2000, showing a reversal in fortune from the highs at the start of the year for both sectors. Instead, biotechnology-themed funds led the way, according to the latest Lipper UK Unit Trust/ Oeic Quarterly survey. The two best performing funds in the second quarter were biotech/healthcare portfolios, Framlington Health, which returned 30.49% over the period, and City Financial Bio Tech, which returned 21.69%. Steve Lipper, global marketing director at Lipper, said: ...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes